Status of bipolar disorder research

Clément, Sarah; Singh, Swaran P.; Burns, Tom

doi:10.1192/bjp.182.2.148

Cited by 41 publications

(32 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although there are no specific data on SGAs published in this field, some authors, also applying bibliometric tools, have reported the research activity in the field of schizophrenia as superior to that of other fields of psychiatry [17]. These authors also suggest that the attraction of research on schizophrenia may have been positively affected by the clinical perception of the greater seriousness of the illness compared to other psychiatric illnesses.…”

Section: Discussionmentioning

confidence: 93%

Thirty years of scientific research on second-generation antipsychotic drugs in Japan: A bibliometric analysis

López‐Muñoz¹,

Shinfuku²,

Shen³

et al. 2013

OJPsych

View full text Add to dashboard Cite

Aims: Research on second-generation antipsychotic drugs (SGAs) has experienced great development in last decades. We did a bibliometric study on the scientific publications on SGAs in Japan. Methods: With the EMBASE and MEDLINE databases, we chose papers published from Japan with SGA descriptors. Price's law and Bradford's law has been used as bibliometric indicators for quantitating production and dispersion, respectively, of published papers on SGAs. We also calculated the participation index of different countries, and correlated those bibliometric data with some social and health data from Japan (such as total per capita expenditure on health and gross domestic expenditure on research and development). Results: A sum of 669 original documents were published from Japan from 1982 to 2011. Those results fulfilled Price's law, with scientific production on SGAs showing exponential growth (correlation coefficient r = 0.9261, as against an r = 0.8709 after linear adjustment). The most studied SGAs in Japan were risperidone (n = 192), aripiprazole (n = 109), and olanzapine (n = 106). Division of documents into Bradford zones yielded a nucleus occupied exclusively by the Progress in Neuro-Psychopharmacology and Biological Psychiatry (49 articles). Those publications were in 157 different journals. Seven of the first 10 frequently used journals had an impact factor of being greater than 3. Conclusions: The SGA publications in Japan have been through exponential growth over the studied period, without evidence of reaching a saturation point.

show abstract

Section: Discussionmentioning

confidence: 93%

Thirty years of scientific research on second-generation antipsychotic drugs in Japan: A bibliometric analysis

López‐Muñoz¹,

Shinfuku²,

Shen³

et al. 2013

OJPsych

View full text Add to dashboard Cite

show abstract

“…It has been suggested that aggressive and misleading psychiatric drug promotion reinforces perceptions of biological causes to mental illness, 19 although it is not obvious why this should affect the views on schizophrenia more than those on depression. Considering schizophrenia as more biologically determined than depression is arguably a traditional view in psychiatry, which may both influence and result from the stronger research focus on biological factors in schizophrenia, 20,21 and the limited provision of psychological treatments for patients with schizophrenia. Our findings are more congruent with an ad hoc survey at the annual American Psychiatric Association meeting in 1987 where 63% of participants predicted that within 25 years the diagnosis of schizophrenia would be replaced by a specific biologically defined disease category.…”

Section: Discussionmentioning

confidence: 99%

Aetiology of depression and schizophrenia: current views of British psychiatrists

2009

View full text Add to dashboard Cite

Aims and MethodA postal survey assessed current views of a random sample of 154 British psychiatrists on aetiological factors in depression and schizophrenia.ResultsGenetics, biochemical abnormalities and substance misuse were considered important factors in both illnesses. Beyond that, psychiatrists varied widely in their views. Depression was viewed as a more multifactorial condition with psychological/social factors more important, whereas biological factors were considered more important in schizophrenia. Aetiological factors were thought to vary more in depression than in schizophrenia and discussing them was seen as more important in patients with depression.Clinical ImplicationsPsychiatrists' attitudes are likely to influence treatment. Patients may encounter different views depending on their illness and on the particular psychiatrist's views.

show abstract

“…This view was based on S.M's previous experience of conducting literature reviews on employment and schizophrenia and that there is less funded research and quantity of literature in bipolar disorder in comparison to Schizophrenia (Clement et al 2003).…”

Section: Initial Screening Of Search Outputmentioning

confidence: 99%

Predictors of employment in bipolar disorder: A systematic review

Gilbert

Marwaha

2013

Journal of Affective Disorders

View full text Add to dashboard Cite

Status of bipolar disorder research

Abstract: There is a relative dearth of research activity on bipolar disorder compared with schizophrenia.

Cited by 41 publications

References 19 publications

Thirty years of scientific research on second-generation antipsychotic drugs in Japan: A bibliometric analysis

Thirty years of scientific research on second-generation antipsychotic drugs in Japan: A bibliometric analysis

Aetiology of depression and schizophrenia: current views of British psychiatrists

Predictors of employment in bipolar disorder: A systematic review

Contact Info

Product

Resources

About